NPI: 1992161780 · DENVER, CO 80219 · Federally Qualified Health Center (FQHC) · NPI assigned 01/08/2016
Authorized official AUDAIN, APRIL controls 20+ related entities in our dataset. Read more
| Authorized Official | AUDAIN, APRIL (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 01/08/2016 |
Other providers sharing the same authorized official: AUDAIN, APRIL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 92,800 | $4.30M |
| 2019 | 69,368 | $4.41M |
| 2020 | 64,668 | $3.31M |
| 2021 | 65,307 | $3.69M |
| 2022 | 52,427 | $5.17M |
| 2023 | 39,756 | $5.20M |
| 2024 | 23,945 | $3.35M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 147,061 | 104,248 | $15.64M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 61,439 | 47,703 | $7.35M |
| D0999 | Unspecified diagnostic procedure, by report | 5,522 | 4,356 | $1.25M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9,873 | 7,211 | $1.06M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 5,093 | 3,688 | $640K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5,535 | 3,913 | $519K |
| 90832 | Psychotherapy, 30 minutes with patient | 4,593 | 3,007 | $381K |
| H0025 | Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) | 2,559 | 1,399 | $332K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3,193 | 2,078 | $304K |
| 0012A | 4,321 | 4,203 | $165K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,906 | 1,063 | $160K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 858 | 615 | $159K |
| 0011A | 4,234 | 4,105 | $142K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1,591 | 1,004 | $140K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4,805 | 3,278 | $114K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 8,420 | 6,111 | $103K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 840 | 521 | $69K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 211 | 206 | $63K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 510 | 305 | $57K |
| D0150 | Comprehensive oral evaluation - new or established patient | 1,171 | 1,001 | $53K |
| D1206 | Topical application of fluoride varnish | 2,218 | 1,924 | $50K |
| D1120 | Prophylaxis - child | 1,195 | 1,057 | $45K |
| D0120 | Periodic oral evaluation - established patient | 1,511 | 1,324 | $43K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 380 | 187 | $40K |
| D0330 | Panoramic radiographic image | 694 | 592 | $38K |
| 99215 | Prolong outpt/office vis | 275 | 252 | $36K |
| 0002A | 733 | 719 | $35K | |
| 36415 | Collection of venous blood by venipuncture | 47,855 | 35,186 | $34K |
| 0124A | 659 | 594 | $34K | |
| 0064A | 1,054 | 791 | $31K | |
| 0001A | 669 | 660 | $29K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 180 | 144 | $28K |
| 0071A | 462 | 349 | $21K | |
| 0072A | 338 | 327 | $20K | |
| D0272 | Bitewings - two radiographic images | 750 | 643 | $20K |
| D7140 | Extraction, erupted tooth or exposed root | 170 | 84 | $19K |
| D1110 | Prophylaxis - adult | 320 | 269 | $19K |
| D0220 | Intraoral - periapical first radiographic image | 1,127 | 981 | $17K |
| 11982 | 122 | 116 | $17K | |
| 90480 | 501 | 316 | $16K | |
| D1351 | Sealant - per tooth | 411 | 127 | $16K |
| D0140 | Limited oral evaluation - problem focused | 449 | 402 | $13K |
| D0274 | Bitewings - four radiographic images | 282 | 242 | $12K |
| D0145 | Oral evaluation for a patient under three years of age | 2,181 | 1,496 | $11K |
| 58300 | 59 | 56 | $10K | |
| 0031A | 292 | 242 | $10K | |
| 0054A | 316 | 161 | $9K | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | 166 | 128 | $8K |
| H0001 | Alcohol and/or drug assessment | 68 | 27 | $8K |
| D0230 | Intraoral - periapical each additional radiographic image | 513 | 451 | $7K |
| 20610 | 136 | 66 | $6K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 12 | 12 | $5K |
| 0004A | 196 | 122 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 27 | 25 | $4K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 14 | 13 | $3K |
| 0013A | 87 | 84 | $3K | |
| H0031 | Mental health assessment, by non-physician | 87 | 33 | $3K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 41 | 38 | $3K |
| D0210 | Intraoral - complete series of radiographic images | 23 | 12 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 40,290 | 28,724 | $2K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 627 | 240 | $2K |
| 0052A | 35 | 35 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 751 | 656 | $1K |
| 91322 | 12 | 12 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 30 | 27 | $726.39 |
| 36416 | 1,230 | 906 | $695.11 | |
| 0111A | 12 | 12 | $679.47 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 13,725 | 9,675 | $654.89 |
| 0051A | 12 | 12 | $617.70 | |
| 90688 | 5,518 | 3,284 | $198.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 359 | 332 | $71.36 |
| 90677 | 13 | 12 | $35.28 | |
| D0270 | 12 | 12 | $28.00 | |
| 90686 | 459 | 418 | $23.56 | |
| 90474 | 1,290 | 841 | $6.50 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,186 | 986 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 259 | 254 | $0.00 |
| 90732 | 14 | 12 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 406 | 311 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 68 | 40 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 35 | 12 | $0.00 |
| 90694 | 61 | 41 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 81 | 50 | $0.00 |
| D4342 | 15 | 12 | $0.00 | |
| 99406 | 24 | 12 | $0.00 | |
| 83986 | 16 | 14 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 459 | 328 | $0.00 |
| D0190 | 726 | 312 | $0.00 | |
| 90682 | 17 | 15 | $0.00 | |
| 90715 | 209 | 131 | $0.00 | |
| 90750 | 12 | 12 | $0.00 |